{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:44:16Z","timestamp":1762101856613},"reference-count":25,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.3892\/ijmm.2016.2552","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T16:40:47Z","timestamp":1460133647000},"page":"1686-1696","source":"Crossref","is-referenced-by-count":13,"title":["Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis"],"prefix":"10.3892","volume":"37","author":[{"given":"NAN","family":"LIU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHEN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIBING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEI","family":"GAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUI","family":"CHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUSHENG","family":"TANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOXIA","family":"HU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIANMIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"key20180107234643_b1-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/ajh.23834","article-title":"Acute myeloid leukemia: 2014 update on risk-stratification and management","volume":"89","author":"Estey","year":"2014","journal-title":"Am J Hematol"},{"key":"key20180107234643_b2-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1200\/JCO.2014.58.3518","article-title":"Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia","volume":"33","author":"Chen","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20180107234643_b3-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/10428194.2012.713479","article-title":"Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse","volume":"54","author":"Fong","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"key20180107234643_b4-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ajh.23576","article-title":"Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status","volume":"88","author":"Yoon","year":"2013","journal-title":"Am J Hematol"},{"key":"key20180107234643_b5-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12185-014-1617-8","article-title":"AML\/MDS Working Party: role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients","volume":"100","author":"Kim","year":"2014","journal-title":"Int J Hematol"},{"key":"key20180107234643_b6-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cncr.21132","article-title":"Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid","volume":"104","author":"Pilatrino","year":"2005","journal-title":"Cancer"},{"key":"key20180107234643_b7-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","article-title":"Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia","volume":"25","author":"Quint\u00e1s-Cardama","year":"2011","journal-title":"Leukemia"},{"key":"key20180107234643_b8-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood-2013-03-488114","article-title":"Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors","volume":"123","author":"Bots","year":"2014","journal-title":"Blood"},{"key":"key20180107234643_b9-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3324\/haematol.2013.093278","article-title":"The gene signature in CCAAT-enhancer-binding protein \u03b1 dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors","volume":"99","author":"Liss","year":"2014","journal-title":"Haematologica"},{"key":"key20180107234643_b10-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"key20180107234643_b11-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/sj.leu.2403390","article-title":"Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1","volume":"18","author":"Tang","year":"2004","journal-title":"Leukemia"},{"key":"key20180107234643_b12-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm1160","article-title":"Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway","volume":"11","author":"Insinga","year":"2005","journal-title":"Nat Med"},{"key":"key20180107234643_b13-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.leukres.2009.07.043","article-title":"Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells","volume":"34","author":"Cencic","year":"2010","journal-title":"Leuk Res"},{"key":"key20180107234643_b14-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12967-015-0543-8","article-title":"Excessive proliferation and impaired function of primitive hematopoietic cells in bone marrow due to senescence post chemotherapy in a T cell acute lymphoblastic leukemia model","volume":"13","author":"Jiang","year":"2015","journal-title":"J Transl Med"},{"key":"key20180107234643_b15-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"key20180107234643_b16-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.193474","article-title":"Revisiting the isobole and related quantitative methods for assessing drug synergism","volume":"342","author":"Tallarida","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107234643_b17-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1158\/1078-0432.CCR-11-2432","article-title":"Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD\/SCID\/Il2rg\u2212\/\u2212 mice","volume":"18","author":"Zorzoli","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107234643_b18-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00280-012-1953-4","article-title":"Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro","volume":"70","author":"Huang","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107234643_b19-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/carcin\/bgt019","article-title":"Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2","volume":"34","author":"Witt","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20180107234643_b20-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4161\/epi.23538","article-title":"Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1\/ETO-positive leukemia cells","volume":"8","author":"Barbetti","year":"2013","journal-title":"Epigenetics"},{"issue":"Suppl 1","key":"key20180107234643_b21-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-005-0026-8","article-title":"Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia","volume":"84","author":"Kuendgen","year":"2005","journal-title":"Ann Hematol"},{"key":"key20180107234643_b22-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","article-title":"Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"key":"key20180107234643_b23-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejps.2010.06.011","article-title":"Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells","volume":"41","author":"Chen","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"key20180107234643_b24-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-011-1364-y","article-title":"Addition of a histone deacetylase inhibitor redirects tamoxifentreated breast cancer cells into apoptosis, which is opposed by the induction of autophagy","volume":"130","author":"Thomas","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107234643_b25-ijmm-37-06-1686","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s10495-010-0521-9","article-title":"Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells","volume":"15","author":"Sung","year":"2010","journal-title":"Apoptosis"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2016.2552\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T19:22:22Z","timestamp":1515352942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2016.2552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,4,8]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.3892\/ijmm.2016.2552"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2016.2552","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,8]]}}}